Hopital Arnaud de Villeneuve - CHU de Montpellier
Montpellier, France
NCT Number: NCT05794932
Post-thrombotic syndrome (PTS) is the most frequently observed chronic complication of deep vein thrombosis (DVT), with an estimated cumulative incidence of 20-50%. Endovascular venous recanalization with angioplasty and stenting of obstructive lesions is the recommended treatment option to reduce or correct the symptoms of DVT. However, its impact on the physical capacity and breathlessness of patients has not been fully demonstrated. The heterogeneous evidences of clinical improvement is probably related to the presence or absence of collateral veins developed in these patients with proximal venous obstruction (iliac or iliofemoral with or without inferior vena cava involvement), which ensure the cardiac venous return. The aim of this study is to compare changes in maximal oxygen uptake after endovascular venous recanalization in DVT patients and to evaluate the hemodynamic, respiratory and muscular improvement induced by the restoration of venous flow in the occluded segments.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Montpellier, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Diagnostic Test:
Time frame: From baseline and 8 weeks
Change in VO₂ max is the maximum (max) rate (V) of oxygen (O₂) the body is able to use during exercise from baseline to 8 weeks. It is measured in liters of O2 per minute
Time frame: From baseline and 8 weeks
Maximum aerobic power is measured in watts before and after venous recanalization
Time frame: From baseline and 8 weeks
The isowork power is the power output assessed at the V'O2max before recanalization
Time frame: From baseline and 8 weeks
Maximal exercise cardiac output is the cardiac output assessed by thoracic impedance et peak exercise before and after venous recanalization
Time frame: From baseline and 8 weeks
Exercise change in Inspiratory capacity is the change between rest and peak exercise of the inspiratory capacity (the volume between end-expiratory volume and total lung capacity) before and after venous recanalization
Time frame: From baseline and 8 weeks
Maximal exercise capillary volume is the capillary volume at peak exercise assessed by NO/CO transfer before and after venous recanalization
Time frame: From baseline and 8 weeks
Maximal exercise O2 arterial pressure is the oxygen partial pressure in the arterial blood, assessed at peak exercise, before and after venous recanalization
Time frame: From baseline and 8 weeks
Maximal isometric strength during leg extension is the maximal torque of the leg extension at 90° knee flexion assessed by a torque sensor before and after venous recanalization
Time frame: From baseline and 8 weeks
Lower limb extracellular/total water is the water volume int the body compartments in each lower limb, assessed by a segmental bioelectrical impedancemeter before and after venous recanalization
University Hospital, Montpellier
Other
Exercise Tolerance After Venous Recanalization for Post-thrombotic Syndrome: ETERecaVSPT
Acronym: ETERecaVSPT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03757481
Cardiovascular Diseases, Chronic Thromboembolic Pulmonary Hypertension
Amiens, France
View Trial DetailsNCT03075761
Behavior, Cardiovascular Diseases
Dallas, Texas, United States
View Trial DetailsNCT00633971
Cardiovascular Diseases, Edema
Burlington, Vermont, United States
View Trial DetailsNCT00790335
Cardiovascular Diseases, Deep Vein Thrombosis
Glendale, Arizona, United States
View Trial Details